Risk of congestive heart failure in women treated with trastuzumab (Herceptin) and combination chemotherapy for early-stage breast cancer did not increase over time according to a five-year follow-up of National Surgical Adjuvant Breast and Bowel Project (NSABP) trial B-31, presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
A drug described by some people as a “genius pill” for enhancing cognitive function provided relief to a small group of Rochester breast cancer survivors who were coping with a side effect known as “chemo-brain,” according to a University of Rochester Medical Center study.
Allos Therapeutics, Inc. (Nasdaq: ALTH) announced the initiation of patient enrollment in a Phase I/IIa open-label, multi-center study of sequential PDX (pralatrexate) and gemcitabine with vitamin B12 and folic acid supplementation in patients with relapsed or refractory non-Hodgkin’s lymphoma (NHL) or Hodgkin’s disease.
New guidelines for the treatment of post-traumatic stress disorder have been accredited by the National Health and Medical Research Council (NHRMC) and are paving the way to more evidence-based treatment of mental health problems.
Januvia (scientific name sitagliptin), a new drug designed to improve blood sugar control in patients with type 2 diabetes, should not be used because the drug?s long-term safety is still unknown, Public Citizen writes in a new June posting on its WorstPills.org Web site.
Massey scientists have discovered a weak link in human digestion that could revolutionise healthy eating and medical treatment for the chronically-ill.
A new study analyzing men with localized prostate cancer shows that the specialty of the physician they see can influence the type of therapy they ultimately receive.
Despite modest overall improvements in breast cancer survival rates for women with advanced disease over the last two decades, the rates for black women have not improved and the difference in life expectancy between white and black women continues to widen, according to researchers at the University of Texas M. D. Anderson Cancer Center.
Researchers have discovered the first inherited gene mutation that increases a person’s risk for chronic lymphocytic leukemia (CLL), one of the most common forms of the disease.
Every year, tens of thousands of men and women from every county of Michigan and around the country turn to the University of Michigan Health System for advanced care for heart disease, blood vessel disorders and strokes. The number of visits for that care has nearly doubled in the last decade.